Chemical investigation and in vitro antimalarial activity of Tabebuia ochracea ssp neochrysantha

A study of Tabebuia ochracea ssp. neochrysantha, a plant traditionally used in the Amazon against malaria was pursued. Bioactivity was tested in vitro against Plasmodium berghei and Plasmodium falciparum (FcB2 chloroquine-resistant strain). Inhibitory activity was determined by measuring parasite H-3-hypoxanthine incorporation. Fractionation of the chloroformic extract of P. ochracea (inner stem bark) afforded five furanonaphthoquinones. The highest antimalarial activity against P. berghei was given by a mixture of two compounds which could not be separated, but the isomeric structures of 5- and 8-hydroxy-2-(1'-hydroxy)-ethyl-naphtho-[2,3-b]-furan-4,9-dione (I and 2) were determined from spectroscopic data. The 50% inhibitory concentration (IC50) values obtained with the mixture of compounds I and 2 were 1.67 x 10(-7) M for P. berghei and 6.77 x 10(-7) for the FcB2 chloroquine resistant strain of P. falciparum. For the former parasite, the IC50 value for chloroquine was 5 x 10(-8) M. That for P. falciparum was 1.1 x 10(-7) M. These results indicate that the furanonaphthoquinones isolated from T. ochracea are potential antimalarial compounds.